can tirzepatide cause heart problems for Failure in Patients with Obesity Tirzepatide and Cardiovascular Outcomes in

Semaglutide Oral Transmucisal Film Strips are another option for patents that are not interested in taking an injection

Achieve your goals without extreme dieting or exhausting workouts.

GLP1 Probiotics and Gut Microbiome Support Probioitcs contribute to a balanced gut microbiome that fosters natural glp1 production

Cortisol and serotonin balance to support weight management and emotional resilience

Our New York medical weight loss treatment is personalized, evidence-based, and 100% online

PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care, Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity. Key Highlights: Digbi GLP-Fit uses the science of precision biology to identify the best treatment path for obesity for an individual with 87% accuracy, which may include 1) only precision nutrition, 2) a combination of precision nutrition and lower-cost drugs like Metformin, or 3) a combination of precision nutrition and GLP-1 medications